Latest News about JNJ
Recent news which mentions JNJ
7 High-Growth S&P 500 Stocks to Buy Now
October 12, 2023
From InvestorPlace
From Benzinga
Where can you find entertainment, beaches, jobs, low cost of living and more? Here are some of the best places to live in Florida.
October 12, 2023
From MarketWatch
2 No-Brainer Dividend King Stocks to Buy Right Now
October 11, 2023
From Motley Fool
Family Dollar recalls P&G, J&J, Colgate products in 23 states due to incorrect temperature storage
October 10, 2023
From MarketWatch
Looking At Johnson & Johnson's Recent Unusual Options Activity
October 09, 2023
Tickers
JNJ
From Benzinga
From InvestorPlace
Meet the 3 Dividend Kings Warren Buffett Is Betting $21 Billion On
October 09, 2023
From Motley Fool
3 Pharma Stocks to Dump Before the Damage Is Done
October 08, 2023
From InvestorPlace
My Top Under-Appreciated Dividend King to Buy in October
October 08, 2023
From Motley Fool
IPOs are out of fashion. Here’s what companies are doing instead.
October 06, 2023
From MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
October 05, 2023
From Benzinga
Johnson & Johnson Has Potential To Drive Its Pharma And MedTech Franchises, Says Bullish Analyst
October 05, 2023
Tickers
JNJ
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023
October 05, 2023
From Benzinga
3 Ways AI Can Help Healthcare Companies Grow
October 05, 2023
From Motley Fool
2 Magnificent Dividend Kings to Buy Now
October 05, 2023
From Motley Fool
3 Historically Cheap Dow Stocks to Buy Hand Over Fist in October
October 05, 2023
From Motley Fool
7 Top Healthcare Stocks That Pay Dividends
October 04, 2023
From InvestorPlace
From Benzinga
Johnson & Johnson Sees Legal Win In Talc Powder Cancer Claims
October 04, 2023
Tickers
JNJ
From Benzinga
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
October 03, 2023
From Benzinga
From Benzinga
Higher Rates, Lower Leverage: Growth Stocks To Struggle While AI Offers Hope, Goldman Sachs Analysts Say
October 03, 2023
From Benzinga
From Benzinga
Medicare drug price negotiations move forward with all drugmakers participating, White House says
October 03, 2023
From MarketWatch
Johnson & Johnson Urged To Expand Access Tuberculosis Medication
October 02, 2023
Tickers
JNJ
From Benzinga
Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?
October 01, 2023
From Motley Fool
Is Kenvue Stock Too Pricey to Buy?
September 30, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.